Cytosorbents - 5 Year Stock Price History | CTSO

Historical daily share price chart and data for Cytosorbents since 2014 adjusted for splits. The latest closing stock price for Cytosorbents as of June 14, 2019 is 6.06.
  • The all-time high Cytosorbents stock price is 14.99, which is 147.4% above the current share price.
  • The Cytosorbents 52-week high stock price is 14.80, which is 144.2% above the current share price.
  • The Cytosorbents 52-week low stock price is 5.92, which is 2.3% below the current share price.
  • The average Cytosorbents stock price for the last 52 weeks is 9.47.
Cytosorbents Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 7.3888 7.8500 8.5600 5.9200 6.0600 -25.00%
2018 9.8895 6.5500 14.8000 6.5500 8.0800 24.31%
2017 5.3563 5.6500 7.0500 3.4500 6.5000 19.27%
2016 4.8439 5.6800 6.7300 3.2100 5.4500 -2.15%
2015 7.6143 11.0000 14.9900 5.2000 5.5700 -44.02%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.195B $0.023B
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.051B 28.16
Medtronic (MDT) Ireland $130.762B 18.68
Stryker (SYK) United States $72.931B 26.03
Boston Scientific (BSX) United States $56.210B 26.95
Baxter (BAX) United States $39.757B 25.06
Zimmer Biomet Holdings (ZBH) United States $24.054B 15.45
Smith & Nephew SNATS (SNN) United Kingdom $18.710B 0.00
ResMed (RMD) United States $16.933B 32.35
Canopy Growth (CGC) Canada $14.186B 0.00
Bio-Rad Laboratories (BIO) United States $8.893B 47.15
Aurora Cannabis (ACB) Canada $7.667B 75.60
Hill-Rom Holdings (HRC) United States $6.972B 21.14
Insulet (PODD) United States $6.868B 500.39
Perrigo (PRGO) Ireland $5.872B 9.93
Haemonetics (HAE) United States $5.747B 46.91
GW Pharmaceuticals (GWPH) United Kingdom $5.154B 0.00
ICU Medical (ICUI) United States $4.983B 29.73
Hutchison China MediTech (HCM) China $3.506B 0.00
Neogen (NEOG) United States $3.232B 52.55
NuVasive (NUVA) United States $3.005B 24.54
Agios Pharmaceuticals (AGIO) United States $2.821B 0.00
National Vision Holdings (EYE) United States $2.350B 50.07
Quidel (QDEL) United States $2.233B 23.18
Aphria (APHA) $1.702B 0.00
Cardiovascular Systems (CSII) United States $1.388B 797.00
Phibro Animal Health (PAHC) United States $1.174B 17.58
AtriCure (ATRC) United States $1.144B 0.00
VAREX IMAGING (VREX) United States $1.089B 23.12
Lantheus Holdings (LNTH) United States $1.027B 27.27
OrganiGram Holdings (OGI) Canada $0.969B 0.00
NanoString Technologies (NSTG) United States $0.909B 0.00
PetIQ (PETQ) United States $0.837B 20.34
Quanterix (QTRX) United States $0.834B 0.00
Omeros (OMER) United States $0.795B 0.00
MacroGenics (MGNX) United States $0.743B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.724B 20.31
TG Therapeutics (TGTX) United States $0.639B 0.00
Cerus (CERS) United States $0.629B 0.00
Surmodics (SRDX) United States $0.558B 81.06
OraSure Technologies (OSUR) United States $0.530B 24.40
LeMaitre Vascular (LMAT) United States $0.513B 24.82
Meridian Bioscience (VIVO) United States $0.497B 15.18
Evolus (EOLS) United States $0.377B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.348B 0.00
Vapotherm (VAPO) United States $0.339B 0.00
BioLife Solutions (BLFS) United States $0.333B 104.06
Utah Medical Products (UTMD) United States $0.300B 20.78
Zynex (ZYXI) United States $0.282B 29.17
Rockwell Medical (RMTI) United States $0.241B 0.00
Bovie Medical (APYX) United States $0.213B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Owens & Minor (OMI) United States $0.177B 3.75
Fonar (FONR) United States $0.135B 7.09
Female Health (VERU) United States $0.127B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
BRAINSWAY LTD (BWAY) Israel $0.094B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
United-Guardian (UG) United States $0.087B 19.15
Neurotrope (NTRP) United States $0.080B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.044B 15.21
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Senestech (SNES) United States $0.034B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.026B 0.00
Insys Therapeutics (INSY) United States $0.025B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.016B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.82